Global Industry Analysts, Inc., Oct 2011, Pages: 749
This report analyzes the worldwide markets for Autoimmune Disease Therapeutics in US$ Million by the following Therapeutic Class: Rheumatoid Arthritis (Biologics), Multiple Sclerosis, Psoriasis
Timely Data Resources, Inc., Oct 2011, Pages: 15
Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the senior
GlobalData, Dec 2010, Pages: 84
of Arthritis and Musculoskeletal and Skin Diseases Snapshot
National Institute of Arthritis and Musculoskeletal and Skin Diseases Overview
Key Information
Key Facts
National Institute of Arthritis
Harvard Health Publications/Staywell, Jan 2011, Pages: 49
. But things are changing. Treatments are better, and plenty of people age well without much arthritis. People also tend to think of arthritis as a single disease. In fact, there are more than 100 different
Global Markets Direct, Dec 2010, Pages: 84
of Arthritis and Musculoskeletal and Skin Diseases Snapshot
National Institute of Arthritis and Musculoskeletal and Skin Diseases Overview
Key Information
Key Facts
National Institute
Global Markets Direct, Dec 2010, Pages: 84
of Figures
National Institute of Arthritis and Musculoskeletal and Skin Diseases Snapshot
National Institute of Arthritis and Musculoskeletal and Skin Diseases Overview
Key Information
Key Facts
GBI Research, Dec 2009, Pages: 201
for the autoimmune diseases therapeutics market from 2000 to 2008, forecast forward to 2015
- Analysis of the leading therapeutic segments including rheumatoid arthritis, multiple sclerosis, systemic lupus
GlobalData, Oct 2011, Pages: 31
of industry experts.
Scope
- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries
Decision Resources, Inc., March 2005, Pages: 13
According to recent clinical studies, the key to achieving optimal outcomes in rheumatoid arthritis (RA) is to diagnose and treat it as early as possible. The need to develop more-sensitive and more
Global Markets Direct, Dec 2010, Pages: 31
and industry-specific third party sources, put together by Global Markets Direct’s team.
Scope
- Horizon Pharma, Inc. - Brief company overview including business description, key information and facts
Timely Data Resources, Inc., Feb 2012
important information about a disease or procedure, including definitions, caveats, historical notes, and other useful facts.
Ranked Items
Ranked lists of the top 300 inpatient diseases, in/outpatient
Bizacumen Inc., Nov 2009, Pages: 394
Demand for orthopedic instrumentation products is driven by considerable rise in osteoporosis, arthritis, and joint diseases. An aging population, increasingly active lifestyles, and an expanding
GlobalData, Nov 2011, Pages: 20
fusing with their target cells. The laboratory tests of the company include Fibromyalgia, Lassa fever, Gulf War Syndrome, Lupus, Sjogren's, Juvenile rheumatoid arthritis, Grave's disease, Breast Cancer
GlobalData, Nov 2010, Pages: 61
information and facts, and its locations and subsidiaries.
- Review of current pipeline of Rigel Pharmaceuticals, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy
Global Markets Direct, Nov 2010, Pages: 61
information and facts, and its locations and subsidiaries.
- Review of current pipeline of Rigel Pharmaceuticals, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy
GlobalData, Nov 2010, Pages: 31
third party sources, put together by Global Markets Direct’s team.
Scope
- Neovacs SA - Brief company overview including business description, key information and facts, and its locations
GlobalData, Nov 2010, Pages: 33
third party sources, put together by Global Markets Direct’s team.
Scope
- Phytomedics, Inc. - Brief company overview including business description, key information and facts, and its locations
GlobalData, Nov 2010, Pages: 33
third party sources, put together by Global Markets Direct’s team.
Scope
- Txcell SA - Brief company overview including business description, key information and facts, and its locations
Global Markets Direct, Nov 2010, Pages: 33
third party sources, put together by Global Markets Direct’s team.
Scope
- Phytomedics, Inc. - Brief company overview including business description, key information and facts, and its locations
Global Markets Direct, Nov 2010, Pages: 33
third party sources, put together by Global Markets Direct’s team.
Scope
- Txcell SA - Brief company overview including business description, key information and facts, and its locations
